MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F9157 to DMS Pharmaceutical Group Inc on August 27, 2026, for the procurement of Meloxicam Tablets. This award was issued as a delivery order under the broader commercial items contract SPE2DX25D9900, which was managed by the DLA Troop Support Medical Supply Chain. The total contract price is 270.00 dollars, covering the delivery of six bottles at a unit price of 45.00 dollars. The order specifies that shipment, inspection, and acceptance will occur at the destination under FOB destination terms. The overarching base administrative contract was established on April 2, 2025, and includes standard Part 12 clauses and Net 30 payment terms. This specific procurement is identified by NSN 6505015413243 and PR 7018084122, ensuring the supply of necessary medical pharmaceuticals to the Department of Defense.
General Info
Contract Value
$270Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
